β‐Elemene Rescues Radiation‐Induced Enteritis by Orchestrating a Host‐Microbiome Circuit That Fuels Epigenetic DNA Repair
Source abstract
Abstract
ABSTRACT Radiation‐induced enteritis (RIE) is a severe, dose‐limiting toxicity of cancer radiotherapy lacking mechanism‐based therapies. While the gut microbiome regulates radiation injury, harnessing it therapeutically remains challenging. Here, we show that the natural product β‐elemene protects against RIE through a synergistic mechanism coordinating host and microbial responses. β‐elemene directly rescues the radiation‐disrupted interaction between the lactate transporter MCT1 and its chaperone CD147 in intestinal epithelial cells, priming them for enhanced lactate uptake. Concurrently, β‐elemene selectively enriches for Lactobacillus gasseri , increasing intestinal lactate production. The convergence of host priming and elevated lactate availability triggers a metabo‐epigenetic cascade. Specifically, lactate drives the lactylation of the chromatin‐associated protein RBBP4, which in turn recruits EP300 to activate the transcription of essential DNA damage repair genes. We further identify EP300 as a lactyl‐transferase, establishing a self‐amplifying positive feedback loop that robustly enhances the repair signal. Our findings delineate a complete drug‐microbe‐metabolite‐epigenome axis, establishing a ‘prime‐and‐fuel’ therapeutic strategy where a single agent orchestrates inter‐kingdom communication to promote tissue regeneration.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Effects of Radiation Exposure · DNA Repair Mechanisms · Genomics, phytochemicals, and oxidative stress
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Gastrointestinal Surgery Affiliated Hospital and Medical School of Nantong University Nantong China
Department of General Surgery Binhai County People's Hospital Yancheng Jiangsu China
Research Center of Clinical Medicine Affiliated Hospital of Nantong University Nantong China
Nantong Key Laboratory of Gastrointestinal Oncology Nantong China
Funding
National Natural Science Foundation of China
References (79)
Show source-provided references
1. 10.1038/nrgastro.2014.4610.1038/nrgastro.2014.46 ↗
2. 10.1016/j.bpg.2020.10170710.1016/j.bpg.2020.101707 ↗
3. Bhutta B. S. · 2025
4. 10.1177/204062231351073010.1177/2040622313510730 ↗
5. Radiation‐induced Gastrointestinal Toxicity. Pathophysiology, Approaches to Treatment and Prophylaxis
6. 10.1007/s00066‐005‐1390‐y10.1007/s00066‐005‐1390‐y ↗
7. 10.1038/s41467‐022‐28744‐410.1038/s41467‐022‐28744‐4 ↗
8. Holdemanella Biformis Augments Washed Microbiota Transplantation for the Treatment of Radiation Enteritis10.1136/gutjnl-2025-335230 ↗
9. 10.1016/j.tem.2023.05.00610.1016/j.tem.2023.05.006 ↗
10. 10.1136/gutjnl‐2017‐31427910.1136/gutjnl‐2017‐314279 ↗
11. 10.1016/j.radonc.2020.01.01110.1016/j.radonc.2020.01.011 ↗
12. 10.3748/wjg.v30.i19.260310.3748/wjg.v30.i19.2603 ↗
13. 10.1016/j.ijbiomac.2024.13849710.1016/j.ijbiomac.2024.138497 ↗
14. 10.1016/j.biopha.2021.11260310.1016/j.biopha.2021.112603 ↗
15. 10.1016/j.phrs.2020.10537610.1016/j.phrs.2020.105376 ↗
16. 10.1038/s12276‐018‐0146‐610.1038/s12276‐018‐0146‐6 ↗
17. 10.1002/anie.20201633010.1002/anie.202016330 ↗
18. 10.1002/adma.20220739110.1002/adma.202207391 ↗
19. 10.1016/j.jare.2023.08.01810.1016/j.jare.2023.08.018 ↗
20. 10.3389/fphar.2021.62100310.3389/fphar.2021.621003 ↗
21. 10.1016/j.ijrobp.2022.08.00710.1016/j.ijrobp.2022.08.007 ↗
22. 10.1001/archsurg.1970.0134028003000910.1001/archsurg.1970.01340280030009 ↗
23. 10.1038/s41586‐023‐06832‐910.1038/s41586‐023‐06832‐9 ↗
24. 10.1093/nar/gkad106910.1093/nar/gkad1069 ↗
25. 10.1093/nar/gkaa105710.1093/nar/gkaa1057 ↗
26. 10.1093/nar/gkz43010.1093/nar/gkz430 ↗
27. 10.1038/nrmicro.2017.5810.1038/nrmicro.2017.58 ↗
28. 10.1073/pnas.200353711710.1073/pnas.2003537117 ↗
29. 10.1158/0008‐5472.CAN‐10‐282810.1158/0008‐5472.CAN‐10‐2828 ↗
30. 10.1038/nm.412810.1038/nm.4128 ↗
31. Expression of Phosphorylated Histone H2AX as a Surrogate of Cell Killing by Drugs That Create DNA Double‐strand Breaks
32. Decay of Gamma‐H2AX Foci Correlates With Potentially Lethal Damage Repair and P53 Status in Human Colorectal Carcinoma Cells
33. 10.1073/pnas.201417611710.1073/pnas.2014176117 ↗
34. 10.1016/j.tig.2020.12.00310.1016/j.tig.2020.12.003 ↗
35. 10.1016/j.molcel.2010.02.00910.1016/j.molcel.2010.02.009 ↗
36. 10.1038/s41467‐023‐43519‐110.1038/s41467‐023‐43519‐1 ↗
37. 10.1158/2159‐8290.CD‐21‐038510.1158/2159‐8290.CD‐21‐0385 ↗
38. 10.1002/imt2.1110.1002/imt2.11 ↗
39. 10.1038/s41418‐024‐01423‐110.1038/s41418‐024‐01423‐1 ↗
40. 10.1111/bph.1633210.1111/bph.16332 ↗
41. 10.1016/j.celrep.2025.11609110.1016/j.celrep.2025.116091 ↗
42. Multi‐Omics Analyses of Radiation Survivors Identify Radioprotective Microbes and Metabolites10.1126/science.aay9097 ↗
43. 10.1038/s41571‐025‐01052‐810.1038/s41571‐025‐01052‐8 ↗
44. 10.1080/19490976.2024.243164310.1080/19490976.2024.2431643 ↗
45. 10.1111/1574‐6976.1202110.1111/1574‐6976.12021 ↗
46. Dietary Lactobacillus‐Derived Exopolysaccharide Enhances Immune‐Checkpoint Blockade Therapy10.1158/2159-8290.CD-21-0929 ↗
47. 10.1126/sciimmunol.abn070410.1126/sciimmunol.abn0704 ↗
48. Procoagulant and Antimicrobial Effects of Chitosan in Wound Healing10.3390/ijms22137067 ↗
49. 10.1021/acsami.3c0659910.1021/acsami.3c06599 ↗
50. 10.1038/nature1884910.1038/nature18849 ↗
51. 10.1126/science.aam994910.1126/science.aam9949 ↗
52. 10.1016/j.chom.2015.03.00510.1016/j.chom.2015.03.005 ↗
53. 10.1016/j.jhep.2014.04.03510.1016/j.jhep.2014.04.035 ↗
54. 10.1016/j.cell.2020.11.04310.1016/j.cell.2020.11.043 ↗
55. 10.2147/IJN.S17452710.2147/IJN.S174527 ↗
56. 10.1093/jb/mvv12710.1093/jb/mvv127 ↗
57. 10.1089/ars.2013.548910.1089/ars.2013.5489 ↗
58. 10.1038/nrm354610.1038/nrm3546 ↗
59. 10.1016/j.canlet.2011.12.01210.1016/j.canlet.2011.12.012 ↗
60. 10.2174/09298671280383333510.2174/092986712803833335 ↗
61. 10.1021/acs.chemrev.8b0053210.1021/acs.chemrev.8b00532 ↗
62. 10.1186/s11658‐021‐00261‐010.1186/s11658‐021‐00261‐0 ↗
63. 10.1186/s12943‐021‐01316‐810.1186/s12943‐021‐01316‐8 ↗
64. 10.1186/s13045‐024‐01527‐810.1186/s13045‐024‐01527‐8 ↗
65. 10.3390/metabo1101002810.3390/metabo11010028 ↗
66. 10.1038/s41392‐024‐01828‐x10.1038/s41392‐024‐01828‐x ↗
67. 10.1038/s41416‐023‐02522‐510.1038/s41416‐023‐02522‐5 ↗
68. 10.1038/nrc357910.1038/nrc3579 ↗
69. 10.1016/j.mam.2012.05.00310.1016/j.mam.2012.05.003 ↗
70. 10.1136/gut.2011.23919410.1136/gut.2011.239194 ↗
71. 10.1126/science.116620210.1126/science.1166202 ↗
72. 10.1113/jphysiol.2001.01424110.1113/jphysiol.2001.014241 ↗
73. 10.1111/j.1469‐7793.1998.719ba.x10.1111/j.1469‐7793.1998.719ba.x ↗
74. 10.1016/j.cell.2013.03.00410.1016/j.cell.2013.03.004 ↗
75. 10.1126/sciadv.abi669610.1126/sciadv.abi6696 ↗
76. 10.15252/embj.20159259510.15252/embj.201592595 ↗
77. 10.1096/fj.07‐9574LSF10.1096/fj.07‐9574LSF ↗
78. Anti‐Tumor Drug Discovery Based on Natural Product Beta‐Elemene: Anti‐Tumor Mechanisms and Structural Modification10.3390/molecules26061499 ↗
79. 10.1016/j.bpc.2006.02.00710.1016/j.bpc.2006.02.007 ↗